Atezolizumab-induced psoriasis in a patient with metastatic lung cancer—a case report

Immune checkpoint inhibitors, now FDA-approved, are being increasingly used for diverse cancer types. Dermatological complications are most frequent immune-related adverse events during immune checkpoints inhibitors therapies. There is no case reporting psoriasis exacerbation from Asia until now. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Mian, Shi, Min, Li, Tao, Wang, Qifeng, Wu, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798521/
https://www.ncbi.nlm.nih.gov/pubmed/35117743
http://dx.doi.org/10.21037/tcr.2020.03.57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798521/
https://www.ncbi.nlm.nih.gov/pubmed/35117743
http://dx.doi.org/10.21037/tcr.2020.03.57

Ejemplares similares